ONC

NASD BeOne Medicines Ltd. Sponsored ADR
Oct 8, 2026 · 6:08 AM ET LAST TRADE Market Closed

$353.40 ↓ -10.62 (-2.92%) Trading Down from the previous close of $364.02

YTD change
+16.32%
vs 20-day SMA
-1.34%
vs 200-day SMA
+10.11%

Price ranges

Previous day
$359.41 $367.57
open $360.01 close $364.02
+$4.01 (+1.11%)
Today
$0.00 $0.00
$353.40
Past week
$349.74 $371.09
from $365.94 now $353.40
-$12.54 (-3.43%)
Past month
$336.95 $376.50
from $351.00 now $353.40
+$2.40 (+0.68%)
This year
$253.95 $380.00
from $303.81 now $353.40
+$49.59 (+16.32%)

Price & Performance

+51.83 (+16.60%) / 6M

$250.94$296.02$341.11$386.19Apr 8Jul 9Oct 7

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 8.3% away from all-time highs of $385.22
  • ONC is up 16% since the beginning of the year
  • ONC is up 1% over the past 12 months
  • ONC is up 1% over the past 1 month
  • 2% of all ONC investors are betting against ONC

ONC reads neutral: price sits above one of the two key moving averages, the 12-month move is +3.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $2.05
Earnings momentum -9.0% Quarterly EPS growth
Quarterly change -9.0%

Valuation

P/E ratio N/A
Enterprise value $38.9B
Beta 0.28

Balance sheet & scale

Income$657.2K
Revenue$6.1B
Cash$5.3B
Debt$2.0M
Income / Debt 0.32×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $36.8B

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $31.51 +1.09%
ARGX argenx SE Sponsored ADR $928.44 -0.22%
WXIBF Wuxi Biologics (Cayman) Inc. $7.49 +10.64%
INCY Incyte Corporation $113.44 +0.63%
IVBXF Innovent Biologics, Inc. $12.80 +4.92%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.